Invest in Your Well-being
Unlock personalized offers for your health, fitness & lifestyle needs
Check Eligibility →
You open the report from a consumer DNA test and see a phrase that immediately grabs your attention: higher risk. Maybe it is heart disease, type 2 diabetes, Alzheimer’s disease, or another condition you have been thinking about in the background for years. For many people, that moment creates an immediate sense of uncertainty, because genetic information is often interpreted as something definitive, even when it is not. In reality, while the number in front of you is real, it is also one of the most widely misunderstood outputs in modern health reporting.
A genetic risk score can provide useful probabilistic information, but it cannot tell you what will definitely happen in your life. As Dr. Dmitry Chebanov, Chief Scientist at Holivita, explains: “What you received is not a prediction of an individual outcome. A polygenic risk score is a statistical estimate derived from population-level associations. Its value lies in providing context for risk assessment, not in forecasting what will happen to a specific person.”
Most consumer DNA tests do not look for a single disease-causing gene. Instead, they calculate what is known as a polygenic risk score, which aggregates thousands of common genetic variants across the genome, each contributing a very small effect. Individually, these variants are usually biologically weak, but when combined they can shift statistical probability in measurable ways.
The result is a position within a distribution of risk observed across large populations. If a report indicates elevated risk, it does not mean a disease is inevitable; it means your relative probability differs from an average reference population.
Modern models are built on extremely large datasets, including multi-ancestry genome-wide association studies such as the CARDIoGRAMplusC4D consortium and related meta-analyses with more than 269,000 cases and over 1.1 million controls in coronary artery disease research. This scale reflects how far genomic science has advanced, but even at this level, results remain probabilistic rather than deterministic.
One analysis shows that each standard-deviation increase in polygenic risk score corresponds to approximately a 35 percent increase in relative risk for coronary artery disease in large-scale GWAS meta-analyses and UK Biobank–based validations. This is meaningful at a population level, but still far from determining individual outcomes.
Importantly, even in groups classified as “high genetic risk,” a substantial proportion of individuals will never develop the associated disease. Genetic elevation shifts probability — it does not define outcome.
A genetic risk result should be treated as a starting hypothesis rather than a conclusion. It can be useful when interpreted alongside family history, clinical data, and other health indicators.
However, the most actionable factors remain modifiable: sleep, nutrition, physical activity, stress regulation, and environmental exposures. These consistently have a stronger influence on long-term health outcomes than any single common genetic variant.
A large-scale analysis combining UK Biobank and other prospective cohorts involving hundreds of thousands of participants (including studies with ~350,000+ individuals) found that individuals with high genetic risk but favorable lifestyle patterns had a substantially lower risk of coronary events compared to those with unfavorable lifestyles. In these analyses, adherence to healthy lifestyle factors was associated with approximately 50–60%+ lower relative risk in high genetic risk groups, and significantly longer life expectancy in follow-up models.
The mechanism connecting genetic predisposition and real-world outcomes is epigenetics. DNA can be seen as a set of biological instructions, while epigenetics acts as the regulatory layer that determines which instructions are active at any given time.
Gene activity is continuously shaped by factors such as sleep, diet, physical activity, stress, and environmental exposure.
This is why two individuals with similar genetic risk profiles can develop completely different health trajectories. Epigenetic regulation helps explain how the same genetic predisposition can lead to different outcomes by modulating gene expression over time.
Another important limitation of polygenic risk scores is variability across populations. Many models were developed primarily using European ancestry datasets, which limits their accuracy when applied to underrepresented populations.
As Dr. Chebanov explains, “A major limitation of many polygenic risk models is that they were trained primarily on datasets of European ancestry. As genetic architecture varies across populations, predictive accuracy often declines when these models are applied to individuals from underrepresented ancestral backgrounds.”
This is not a minor technical detail. Reviews of polygenic risk score development show that the vast majority of early studies were based on European ancestry populations, with only a small fraction of datasets including non-European groups, often estimated at under 5% representation in early GWAS applications.
Genetic risk is not static. It unfolds across decades, shaped by age, cumulative exposures, and changing biological systems. Some genetic effects become more relevant later in life, while others interact continuously with environmental factors.
Even after accounting for genetics, lifestyle, and environment, there is still an element of randomness in biological systems. Human health trajectories are therefore probabilistic rather than deterministic.
A genetic risk result should be treated as a starting hypothesis rather than a conclusion. It can be useful when interpreted alongside family history, clinical data, and other health indicators.
The most actionable factors remain:
These are not abstract wellness suggestions — they are the systems that determine whether genetic susceptibility is expressed or buffered over time.
If a result shows unusually high or clinically significant risk, consultation with a healthcare professional or genetic counselor is appropriate for proper interpretation.
Consumer DNA testing has made genetic data widely accessible, but without context it can easily be misunderstood. A polygenic risk score is not a diagnosis, not a prediction, and not a fixed statement about the future.
As Dr. Chebanov concludes: “DNA provides a biological baseline rather than a predetermined outcome. Genetic variation influences susceptibility, but long-term health trajectories emerge from the interaction between inherited biology, environmental exposures, and behavioral factors throughout life.”
In this sense, genetic information is one layer within a broader biological system where outcomes are continuously shaped by multiple interacting forces, not written in advance.
Note to the Reader: This article has been curated by HT Syndication team. The information provided is intended solely for informational purposes and does not constitute medical advice or endorsement. Please consult a registered medical practitioner for personalized medical advice or before making any decisions regarding your health conditions or treatment options.
Get latest updates on health and wellness along with Brand Stories
Disclaimer: At Health Shots, we are committed to providing accurate, reliable, and authentic information to support your health and well-being. However, the content on this website is intended solely for informational purposes and should not be considered a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider for personalised advice regarding your specific medical condition or concerns.
